New York, May 10, 2018: The scope of the report includes a detailed study of global and regional markets on Global Cancer Biomarkers Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include F.Hoffmann-La Roche Ltd., Abbott Laboratories (U.S.), GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc. (U.S.), Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Inc., Qiagen N.V. and Genomic Health, Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    The Global Cancer Biomarkers Market is expected to exceed more than US$ 157.37 Billion by 2022 at a CAGR of 13.3% in the given forecast period.

    You Can Browse Full Report @: https://www.marketresearchengine.com/cancer-biomarkers-market

    The Global Cancer Biomarkers Market is segmented on the lines of its cancer type, application, profiling technology, biomolecules and regional. Based on cancer type segmentation it covers lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach others. Based on application segmentation it covers diagnostics, drug discovery and development, prognostics, rick assessment, others. Based on profiling technology segmentation it covers omic technologies, imaging technologies, immunoassays, cytogenetic based tests. Based on biomarkers segmentation it covers genetic biomarkers, protein biomarkers, glycoprotein biomarkers.

    The major driving factors of Global Cancer Biomarkers Market are as follows:

    • Development in importance of biological and targeted drug therapies
    • Growing in acquisitions and collaborations
    • Developmental of new technological advancements
    • Growing research for cancer biomarkers
    • Improvement in investment from government, public, and private sectors
    • Rising in clinical trials
    • Expansion in popularity of personalized medicine and companion diagnostics

    The restraining factors of Global Cancer Biomarkers Market are as follows:

    • Expensive of drug development and risk of failure
    • Strict government regulation and repayment policies
    • Sample Collection and Storage department are facing technical problems
    • Adverse effects of cancer drug therapy

    This report provides:

    1) An overview of the global market for Global Cancer Biomarkers Market and related technologies.
    2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
    3) Identifications of new market opportunities and targeted promotional plans for Global Cancer Biomarkers Market.
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    The Global Cancer Biomarkers Market has been segmented as below:

    By Cancer Type Analysis:

    • Lung Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Stomach Cancer
    • Other Cancers

    By Application Analysis:

    • Diagnostics
    • Drug Discovery and Development
    • Prognostics
    • Risk Assessment
    • Others

    By Profiling Technology Analysis:

    • Omic Technologies
    • Imaging Technologies
    • Immunoassays
    • Cytogenetics Based Tests

    By Biomolecules Analysis:

    • Genetic Biomarkers
    • Protein Biomarkers
    • Glycoprotein Biomarkers

    By Regional Analysis:

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    You Can Buy Full Report @: https://www.marketresearchengine.com/cancer-biomarkers-market

     

    Table of Contents

    1 Introduction

    2 Research Methodology

    3 Executive Summary

    4 Premium Insights

    5 Market Overview

    6 Industry Trends

    7 By Tumor Type

    8 Cancer Biomarkers Market, By Type

    9 By Profiling Technologies

    10 By Application

    11 By Geographic Analysis

    12 Competitive Landscape

    13 Company Profiles

    13.1 Introduction

    13.2 Abbott Laboratories

    13.3 Affymetrix, Inc.

    13.4 Illumina, Inc.

    13.5 Qiagen N.V

    13.6 Roche Diagnostics Ltd

    13.7 Agilent Technologies, Inc

    13.8 Quest Diagnostics Inc

    13.9 Merck & Co. Inc.

    13.10 Hologic, Inc

    13.11 Becton, Dickinson and Company

     

    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862

    Country: United States

    Website: https://www.marketresearchengine.com/

     

     

    Source: http://www.financeswire.com/cancer-biomarkers-market-is-supposed-to-reach-us-157-billion-by-2022